Use of Thrombopoietin-Receptor Agonist in CVID-Associated Immune Thrombocytopenia

J Clin Immunol. 2016 Jul;36(5):434-6. doi: 10.1007/s10875-016-0282-5. Epub 2016 Apr 12.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Benzoates / therapeutic use*
  • Common Variable Immunodeficiency / complications*
  • Common Variable Immunodeficiency / diagnosis
  • Common Variable Immunodeficiency / immunology
  • Female
  • Humans
  • Hydrazines / therapeutic use*
  • Purpura, Thrombocytopenic, Idiopathic / diagnosis
  • Purpura, Thrombocytopenic, Idiopathic / drug therapy*
  • Purpura, Thrombocytopenic, Idiopathic / immunology
  • Pyrazoles / therapeutic use*
  • Receptors, Thrombopoietin / agonists*

Substances

  • Benzoates
  • Hydrazines
  • Pyrazoles
  • Receptors, Thrombopoietin
  • eltrombopag